NBIO Financial Statements & Analysis
Complete financial statements for NBIO including income statement, balance sheet, and cash flow statement. Analyze NBIO's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).
Financial Health Score
Financial Health Score
Income Statement
Revenue
0.0% ↓
Net Income
30.0% ↑
Gross Margin
0.0% ↓
Operating Margin
28.0% ↑
Balance Sheet
Current Ratio
-37.3% ↓
Debt to Equity
32.6% ↓
Asset Turnover
25.1% ↑
Cash Flow
Operating Cash Flow
-13.7% ↓
Net Cash Flow
-81.0% ↓
Free Cash Flow
-13.7% ↓
Cash Flow to Debt
-13.7% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | TTM Q2 '24 | TTM Q3 '24 | Change | Impact |
|---|---|---|---|---|
| Revenue | 3.38 | 3.38 | 0.0% | |
| Gross Profit | -295.63K | -295.63K | 0.0% | |
| Operating Income | -2.09M | -1.51M | 28.0% | |
| Net Income | -1.92M | -1.35M | 30.0% | |
| EPS | -0.00 | -0.00 | 32.4% | |
| EBITDA | -1.96M | -1.50M | 23.1% | |
| Gross Margin | -8756694.31% | -8756694.31% | 0.0% | |
| Operating Margin | -61998933.65% | -44641113.74% | 28.0% | |
| Net Income Margin | -57014099.53% | -39922867.30% | 30.0% | |
| R&D Expenses | 161.12K | 104.89K | 34.9% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | TTM Q3 '24 | TTM Q2 '24 | TTM Q1 '24 | TTM Q4 '23 | TTM Q3 '23 |
|---|---|---|---|---|---|
| Revenue | 3.38 | 3.38 | 3.38 | — | — |
| Gross Profit | -295.63K | -295.63K | -181.00K | — | — |
| Operating Income | -1.51M | -2.09M | -2.23M | — | — |
| Net Income | -1.35M | -1.92M | -2.09M | — | — |
| EPS | -0.00 | -0.00 | -0.00 | — | — |
| EBITDA | -1.50M | -1.96M | -1.37M | — | — |
| Gross Margin | -8756694.31% | -8756694.31% | -5361374.41% | — | — |
| Operating Margin | -44641113.74% | -61998933.65% | -66037381.52% | — | — |
| Net Income Margin | -39922867.30% | -57014099.53% | -61830746.45% | — | — |
| R&D Expenses | 104.89K | 161.12K | 171.00K | — | — |
Financial Metrics
Want to dive deeper into NBIO's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics